scholarly article | Q13442814 |
P50 | author | Christian Schwerk | Q87687634 |
Horst Schroten | Q106411127 | ||
Grant Hansman | Q41021048 | ||
Martin Chan | Q50109028 | ||
P2093 | author name string | Stefan Jennewein | |
Stefan Weichert | |||
Anna Koromyslova | |||
Sylvie Y Doerflinger | |||
Ruediger Adam | |||
P2860 | cites work | Rapid evolution of pandemic noroviruses of the GII.4 lineage | Q21089614 |
Structural basis for the recognition of blood group trisaccharides by norovirus | Q24682901 | ||
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation | Q24810360 | ||
X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of Vulnerability | Q27667594 | ||
Norovirus gastroenteritis in immunocompromised patients | Q27694610 | ||
Structural analysis of bovine norovirus protruding domain | Q27702874 | ||
Mechanisms of GII.4 norovirus persistence in human populations | Q28472177 | ||
Genetic and antigenic diversity among noroviruses. | Q52665582 | ||
Detection of human enteric viruses in Japanese clams. | Q54518741 | ||
Measuring H type 1 and H type 2 antigens in human saliva by immunoassay using artificial antigens as standard substances | Q72180721 | ||
Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus | Q81450056 | ||
High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution | Q81936425 | ||
Unifying the epidemiological and evolutionary dynamics of pathogens | Q29619092 | ||
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity | Q30352529 | ||
The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012. | Q30358747 | ||
What is the reservoir of emergent human norovirus strains? | Q30372827 | ||
Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008. | Q30394408 | ||
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. | Q30409563 | ||
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes | Q30425145 | ||
Recombination within the pandemic norovirus GII.4 lineage | Q30428830 | ||
Detection and quantification of rare mutations with massively parallel sequencing | Q30472217 | ||
The state of norovirus vaccines | Q33678125 | ||
Within-host evolution results in antigenically distinct GII.4 noroviruses | Q33744124 | ||
Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice | Q33962224 | ||
Mechanisms of GII.4 norovirus evolution | Q34163802 | ||
Structural requirements for the assembly of Norwalk virus-like particles | Q34335587 | ||
Enteric bacteria promote human and mouse norovirus infection of B cells | Q34446799 | ||
Chronic shedders as reservoir for nosocomial transmission of norovirus | Q34489409 | ||
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant | Q35682819 | ||
Fecal viral load and norovirus-associated gastroenteritis. | Q35793225 | ||
Contribution of intra- and interhost dynamics to norovirus evolution | Q35826200 | ||
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. | Q36098883 | ||
Norovirus infections in symptomatic and asymptomatic food handlers in Japan. | Q36314612 | ||
Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014 | Q36392388 | ||
Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, Thailand | Q36597589 | ||
Norovirus vaccine against experimental human Norwalk Virus illness | Q37144052 | ||
Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013. | Q37375402 | ||
Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides | Q38293732 | ||
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns | Q38353300 | ||
Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses. | Q39604515 | ||
Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype | Q40344592 | ||
Structural Constraints on Human Norovirus Binding to Histo-Blood Group Antigens | Q40700480 | ||
Proposal for a unified norovirus nomenclature and genotyping | Q41513884 | ||
Human noroviruses' fondness for histo-blood group antigens | Q41646214 | ||
Norwalk virus: how infectious is it? | Q45394448 | ||
Existence of multiple genotypes associated with acute gastroenteritis during 6-year survey of norovirus infection in Japan. | Q52009194 | ||
P433 | issue | 2 | |
P921 | main subject | norovirus | Q1142751 |
P577 | publication date | 2017-03-29 | |
P1433 | published in | mSphere | Q27727104 |
P1476 | title | Human Norovirus Evolution in a Chronically Infected Host | |
P478 | volume | 2 |
Q64060326 | Genetic Susceptibility to Human Norovirus Infection: An Update |
Q47553324 | Human Milk Oligosaccharides as Promising Antivirals |
Q90435102 | Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket |
Q57793004 | Human norovirus epitope D plasticity allows escape from antibody immunity without loss of capacity for binding cellular ligands |
Q90639369 | Intra-Host Evolution of Norovirus GII.4 in a Chronic Infected Patient With Hematopoietic Stem Cell Transplantation |
Q47107994 | Molecular Evolution of the VP1 Gene in Human Norovirus GII.4 Variants in 1974-2015. |
Q44611786 | Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization. |
Q90406871 | Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses |
Q92571688 | Nucleic Acid Induced Interferon and Inflammasome Responses in Regulating Host Defense to Gastrointestinal Viruses |
Q64063758 | Structural Basis of Nanobodies Targeting the Prototype Norovirus |
Q88643509 | The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity |